Literature DB >> 3236215

Gastric emptying rates of drug preparations. II. Effects of size and density of enteric-coated drug preparations and food on gastric emptying rates in humans.

N Kaniwa1, N Aoyagi, H Ogata, A Ejima, H Motoyama, H Yasumi.   

Abstract

Enteric-coated granules with different densities and tablets of different sizes were prepared in order to study the effect of these physical properties of dosage forms on the gastric emptying rates in humans. The effect of food on the gastric emptying rate was also studied. Aspirin contained in an enteric-coated product as a marker drug was used to determine the gastric emptying rate by measuring salicylates excreted into the urine. The larger the size of the dosage form, the larger were the values of parameters for estimating the gastric emptying rate such as tlag, tmax and the mean absorption time. There was a significant correlation between the gastric emptying rates and sizes of dosage forms. On the other hand, no effects of density of enteric-coated granules on the gastric emptying rate were observed. The gastric emptying of dosage forms of various sizes or densities tested were prolonged by food. However, the gastric emptying rate of granules was less affected by food than that of tablets.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3236215     DOI: 10.1248/bpb1978.11.571

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  8 in total

Review 1.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

2.  Preparation and evaluation of diltiazem hydrochloride-Gelucire 43/01 floating granules prepared by melt granulation.

Authors:  Shyam Shimpi; Bhaskar Chauhan; K R Mahadik; Anant Paradkar
Journal:  AAPS PharmSciTech       Date:  2004-07-12       Impact factor: 3.246

Review 3.  Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications.

Authors:  P O Gubbins; K E Bertch
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

Review 4.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

5.  Low dose lipid formulations: effects on gastric emptying and biliary secretion.

Authors:  Greg A Kossena; William N Charman; Clive G Wilson; Bridget O'Mahony; Blythe Lindsay; John M Hempenstall; Christopher L Davison; Patrick J Crowley; Christopher J H Porter
Journal:  Pharm Res       Date:  2007-07-27       Impact factor: 4.200

6.  Floating granules of ranitidine hydrochloride-gelucire 43/01: formulation optimization using factorial design.

Authors:  Dasharath M Patel; Natavarlal M Patel; Viral F Patel; Darshini A Bhatt
Journal:  AAPS PharmSciTech       Date:  2007-04-13       Impact factor: 3.246

7.  Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole.

Authors:  Sungyeun Bae; Jihoon Kwon; Si-Beum Lee; In-Jin Jang; Kyung-Sang Yu; SeungHwan Lee
Journal:  Drug Des Devel Ther       Date:  2021-12-21       Impact factor: 4.162

8.  Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulation.

Authors:  Dominick J Angiolillo; Deepak L Bhatt; Frank Lanza; Efthymios N Deliargyris; Jayne Prats; Weihong Fan; Upendra Marathi
Journal:  J Thromb Thrombolysis       Date:  2020-04       Impact factor: 2.300

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.